Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review)

  • Authors:
    • Mei Hong Zhang
    • Hong Tao Man
    • Xiao Dan Zhao
    • Ni Dong
    • Shi Liang Ma
  • View Affiliations

  • Published online on: October 25, 2013     https://doi.org/10.3892/br.2013.187
  • Pages: 41-52
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In this review, the advances in the study of breast cancer molecular classifications and the molecular signatures of the luminal subtypes A and B of breast cancer were summarized. Effective clinical outcomes depend mainly on successful preclinical diagnosis and therapeutic decisions. Over the last few years, the ever‑expanding investigations focusing on breast cancer diagnosis and the clinical trials have provided accumulating information on the molecular characteristics of breast cancer. Specifically, among the estrogen receptor (ER)‑positive types of breast cancer, the luminal subtype A breast cancer has been shown to exhibit good clinical outcomes with endocrine therapy, whereas the luminal subtype B breast cancer represents the more complicated type, diagnostically as well as therapeutically. Furthermore, even in luminal subtype A breast cancer, the resistance to treatment has become the major limitation for endocrine‑based therapy. Accumulating molecular data and further clinical trials may enable more accurate diagnostic and therapeutic decisions. The molecular signatures have emerged as a powerful tool for future diagnosis and therapeutic decisions, although currently available data are limited.
View Figures
View References

Related Articles

Journal Cover

January 2014
Volume 2 Issue 1

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Zhang, M.H., Man, H.T., Zhao, X.D., Dong, N., & Ma, S.L. (2014). Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review). Biomedical Reports, 2, 41-52. https://doi.org/10.3892/br.2013.187
MLA
Zhang, M. H., Man, H. T., Zhao, X. D., Dong, N., Ma, S. L."Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review)". Biomedical Reports 2.1 (2014): 41-52.
Chicago
Zhang, M. H., Man, H. T., Zhao, X. D., Dong, N., Ma, S. L."Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review)". Biomedical Reports 2, no. 1 (2014): 41-52. https://doi.org/10.3892/br.2013.187